Mutated stem cells known as leukemia stem cells (LSCs) initiate and fuel the development of acute myeloid leukemia (AML), an aggressive and usually fatal blood cancer.
Researchers at Albert Einstein College of Medicine describe a promising new strategy for treating and possibly curing acute myeloid leukemia by targeting leukem.
Leave a reply